This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Osborne, R. US regulator wades into stem cell therapies for heart disease. Nat Biotechnol 27, 496–498 (2009). https://doi.org/10.1038/nbt0609-496c
Issue Date:
DOI: https://doi.org/10.1038/nbt0609-496c
This article is cited by
-
Regulation of Stem Cell-Based Therapies in Canada: Current Issues and Concerns
Stem Cell Reviews and Reports (2012)